Umbipro: Opinion on medicine for use outside EU

chlorhexidine

Table of contents

Opinion on medicine for use outside the European Union
Withdrawn opinion

Overview

The opinion for Umbipro for use outside the European Union has been withdrawn at the request of the opinion holder.

Opinion details

Product details
Name of medicinal product
Umbipro
Agency opinion number
H-W-3799
Opinion status
Withdrawn opinion
Active substance
chlorhexidine digluconate
International non-proprietary name (INN) or common name
chlorhexidine
Therapeutic area (MeSH)
Soft Tissue Infections
Anatomical therapeutic chemical (ATC) code
D08AC02
Publication details
Opinion holder

GlaxoSmithKline Trading Services
12 Riverwalk
Citywest Business Campus
Dublin 24
Ireland
Date of opinion
28/04/2016

Product information

19/12/2019 Umbipro H-W-3799-IAIN-0005

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Antiseptics and disinfectants

  • Biguanides and amidines

Therapeutic indication

Umbipro is indicated for prophylaxis of omphalitis (infection of the umbilical cord) in newborn infants.

Assessment history

How useful was this page?

Add your rating